Pharma-Bio Serv, Inc. Annual Cost of Revenue in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Cost of Revenue history and growth rate from 2017 to 2023.
  • Pharma-Bio Serv, Inc. Cost of Revenue for the quarter ending July 31, 2024 was $1.78M, a 41.1% decline year-over-year.
  • Pharma-Bio Serv, Inc. Cost of Revenue for the twelve months ending July 31, 2024 was $8.05M, a 36.9% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Cost of Revenue for 2023 was $11.9M, a 18% decline from 2022.
  • Pharma-Bio Serv, Inc. annual Cost of Revenue for 2022 was $14.5M, a 1.61% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Cost of Revenue for 2021 was $14.8M, a 0.96% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.9M -$2.61M -18% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 $14.5M -$238K -1.61% Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
2021 $14.8M -$142K -0.96% Nov 1, 2020 Oct 31, 2021 10-K 2023-01-30
2020 $14.9M +$1.57M +11.8% Nov 1, 2019 Oct 31, 2020 10-K 2022-02-11
2019 $13.3M +$1.22M +10.1% Nov 1, 2018 Oct 31, 2019 10-K 2021-02-01
2018 $12.1M +$2.66M +28.1% Nov 1, 2017 Oct 31, 2018 10-K 2020-01-29
2017 $9.46M Nov 1, 2016 Oct 31, 2017 10-K 2019-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.